Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatment.

about

Diagnostic and prognostic cytogenetics of chronic myeloid leukaemia: an update.

P2860

Q49993294-861773C3-B0A1-40F9-AC39-8F9A07CA8789

P2860

Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatment.

Item

http://www.wikidata.org/entity/Q48186139

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Clonal chromosomal abnormaliti ...... taphases during CML treatment.

@en

Clonal chromosomal abnormaliti ...... taphases during CML treatment.

@nl

type

Item

label

Clonal chromosomal abnormaliti ...... taphases during CML treatment.

@en

Clonal chromosomal abnormaliti ...... taphases during CML treatment.

@nl

prefLabel

Clonal chromosomal abnormaliti ...... taphases during CML treatment.

@en

Clonal chromosomal abnormaliti ...... taphases during CML treatment.

@nl

P1476

Clonal chromosomal abnormaliti ...... taphases during CML treatment.

@en

P2093

Ghayas C Issa

http://www.w3.org/2001/XMLSchema#string

Graciela Nogueras Gonzalez

http://www.w3.org/2001/XMLSchema#string

Guilin Tang

http://www.w3.org/2001/XMLSchema#string

Keyur Patel

http://www.w3.org/2001/XMLSchema#string

Koji Sasaki

http://www.w3.org/2001/XMLSchema#string

Nicholas J Short

http://www.w3.org/2001/XMLSchema#string

Raja Luthra

http://www.w3.org/2001/XMLSchema#string

Sara Dellasala

http://www.w3.org/2001/XMLSchema#string

P2860

Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib

Clinical significance of Y chromosome loss in hematologic disease.

Long-term molecular and cytogenetic response and survival outcomes with imatinib 400 mg, imatinib 800 mg, dasatinib, and nilotinib in patients with chronic-phase chronic myeloid leukaemia: retrospective analysis of patient data from five clinical tr

The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells.

Results of dasatinib therapy in patients with early chronic-phase chronic myeloid leukemia.

Nilotinib as front-line treatment for patients with chronic myeloid leukemia in early chronic phase.

P304

2084-2091

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2017-07-792143

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P50

Guillermo Garcia-Manero

P577

2017-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28835440

http://www.w3.org/2001/XMLSchema#string

P932

5680612

http://www.w3.org/2001/XMLSchema#string

Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatment.

about

P2860

P2860

Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932